project id: TCGA-TGCT; case submitter id: TCGA-W4-A7U3; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; rna integrity number: 8.3; age at index: 26; days to birth: -9581; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1984; age at diagnosis: 9581; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IS; ajcc clinical t: T1; ajcc pathologic n: NX; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 149.0; icd 10 code: C62.90; last known disease status: not reported; morphology: 9085/3; primary diagnosis: Mixed germ cell tumor; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1185; days to sample procurement: 0; initial weight: 570.0; portion submitter id: TCGA-W4-A7U3-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;